Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Gastroenterology, Ailments & Diseases, Diseases
Cover of the book Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America, E-Book by Edward V. Loftus, Jr, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Edward V. Loftus, Jr, MD ISBN: 9780323323260
Publisher: Elsevier Health Sciences Publication: August 21, 2014
Imprint: Elsevier Language: English
Author: Edward V. Loftus, Jr, MD
ISBN: 9780323323260
Publisher: Elsevier Health Sciences
Publication: August 21, 2014
Imprint: Elsevier
Language: English

By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.

More books from Elsevier Health Sciences

Cover of the book General Anatomy - E-book by Edward V. Loftus, Jr, MD
Cover of the book Atlas of Abdominal Wall Reconstruction E-Book by Edward V. Loftus, Jr, MD
Cover of the book Goldman-Cecil Medicine E-Book by Edward V. Loftus, Jr, MD
Cover of the book Pulmonary Arterial Hypertension, An Issue of Clinics in Chest Medicine, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Quick & Easy Medical Terminology - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Equine Podiatry - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Nails by Edward V. Loftus, Jr, MD
Cover of the book Advances in Cholestatic Liver Diseases, An issue of Clinics in Liver Disease, E-Book by Edward V. Loftus, Jr, MD
Cover of the book PET/MRI: Advances in Instrumentation and Quantitative Procedures, An Issue of PET Clinics, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Clinical Nursing Practices by Edward V. Loftus, Jr, MD
Cover of the book Integration of metabolism by Edward V. Loftus, Jr, MD
Cover of the book Management of Cardiovascular Disease, An Issue of Medical Clinics of North America, E-Book by Edward V. Loftus, Jr, MD
Cover of the book PflegeWissen, Aktivierung und Beschäftigung by Edward V. Loftus, Jr, MD
Cover of the book Mosby's Pocket Guide to Nursing Skills and Procedures by Edward V. Loftus, Jr, MD
Cover of the book Saunders Student Nurse Planner, 2014-2015 - E-Book by Edward V. Loftus, Jr, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy